Author: Summit Cancer Centers

  • dual immunotherapy lung cancer trial Summit First to Offer Exciting New Lung Cancer Dual Immunotherapy Trials
    Summit Cancer Centers | February 7, 2018

    Summit Cancer Centers is First in the Inland Northwest to Obtain a New Generation of Dual Immunotherapy Trials for First Line Metastatic Non-Small Cell Lung Cancer. Immunotherapy has revolutionized the treatment of metastatic non-small cell lung cancer. However, not every patient responds to single agent immunotherapy, either alone or in…
    Read Article

  • Pancreatic Cancer Clinical Trial Promising New Pancreatic Cancer Clinical Trial Now at Summit Cancer Centers
    Summit Cancer Centers | January 23, 2018

    Summit Cancer Centers is first in Washington to offer the Phase 3 Clinical Trial of Immunotherapy AM0010 for Metastatic Adenocarcinoma of the Pancreas. “We are proud to offer an immunotherapy trial for advanced adenocarcinoma of the pancreas,” states Dr. Arvind Chaudhry, Director of Research at Summit Cancer Centers. Current treatments…
    Read Article

  • checkmate920 clinical trial Summit Cancer Centers are First to CHECKMATE Advanced Kidney Cancer
    Summit Cancer Centers | December 23, 2017

    Summit Cancer Centers are  first in Spokane to offer a powerful new dual immunotherapy clinical trial in the treatment of advanced kidney cancer. The significant challenge with kidney cancer is that patients are often diagnosed at an advanced stage, and therefore, are very sick at their initial clinical visit. “We wanted options…
    Read Article

  • Dr. Chaudhry educates about Aliqopa Dr. Arvind Chaudhry Educates Physicians on a New Lymphoma Therapy
    Summit Cancer Centers | November 20, 2017

    Dr. Arvind Chaudhry was recently invited by Bayer to educate physicians on the new lymphoma therapy, Aliqopa. Dr. Arvind Chaudhry, medical oncologist and medical director of Summit Cancer Centers, was recently invited to educate physicians on the FDA approval of the follicular lymphoma drug, Aliqopa (copanlisib). Aliqopa belongs to a new class of drugs that…
    Read Article

  • cancer treatment wellness conference Moving Beyond Cancer to Wellness Conference
    Summit Cancer Centers | June 30, 2017

    Join us for a free wellness conference designed to provide education on wellness after cancer. Saturday, Sept. 23, 2017 All cancer patients, survivors, caregivers, friends, families and healthcare professionals are invited to attend this wellness conference. Lunch will be provided, plus raffle prizes and swag provided by local vendors. This…
    Read Article

  • Summit and SCCA Proud Bloomsday Sponsors
    Summit Cancer Centers | May 5, 2017

    Summit Cancer Centers and Seattle Cancer Care Alliance are Sponsors of the 2017 Bloomsday Race Crew Party. Summit Cancer Centers and Seattle Cancer Care Alliance are very proud to co-sponsor the 2017 Bloomsday Race Crew  dinner to celebrate the contributions of approximately 700 Bloomsday volunteers. All of the volunteers’ efforts…
    Read Article

  • Technology Focus – CyberKnife Treatment for Brain Metastases
    Karie-Lynn Kelly, MD | September 22, 2016

    CyberKnife®  offers new hope to cancer patients diagnosed with Brain Metastases. Metastatic brain cancer occurs when cancer spreads to the brain from another part of the body. Approximately 20-40% of people with cancer will develop brain metastases. The most common types of cancer to spread to the brain are lung…
    Read Article